| Literature DB >> 34996377 |
Liluo Nie1, Yanchun Jiang1, Zongxia Lv1, Xiaomin Pang1, Xiulin Liang1, Weiwei Chang1, Jinou Zheng2.
Abstract
BACKGROUND: Temporal lobe epilepsy (TLE) is commonly refractory. Epilepsy surgery is an effective treatment strategy for refractory epilepsy, but patients with a history of focal to bilateral tonic-clonic seizures (FBTCS) have poor outcomes. Previous network studies on epilepsy have found that TLE and idiopathic generalized epilepsy with generalized tonic-clonic seizures (IGE-GTCS) showed altered global and nodal topological properties. Alertness deficits also were found in TLE. However, FBTCS is a common type of seizure in TLE, and the implications for alertness as well as the topological rearrangements associated with this seizure type are not well understood.Entities:
Keywords: Alertness; Focal to bilateral tonic-clonic seizures; Functional networks; Graph theory; Temporal lobe epilepsy
Mesh:
Year: 2022 PMID: 34996377 PMCID: PMC8740350 DOI: 10.1186/s12883-021-02525-w
Source DB: PubMed Journal: BMC Neurol ISSN: 1471-2377 Impact factor: 2.474
The demographic, clinical characteristic and alertness of two groups with TLE and HCs
| TLE-non-FBTCS (18) | TLE- FBTCS | Health control | P value | ||
|---|---|---|---|---|---|
| Gender (M/F) | 8/10 | 11/10 | 9/13 | 0.744(Chi-square) | |
| Age (M ± SD) | 29.722 ± 8.857 | 33.523 ± 8.376 | 29.772 ± 6.279 | 0.212(ANOVA) | |
| Education years, median (range) | 15(9-16) | 12(9-16) | 15(10-18) | 0.103(Kruskal-Wallis) | |
| Side (R/L) | 11/7 | 11/10 | / | 0.584(Chi-square) | |
| Hippocampal sclerosis (Yes or No) | 8/10 | 12/9 | / | 0.429(Chi-square) | |
| Age of epilepsy onset (M ± SD) | 21.278 ± 10.665 | 21.238 ± 11.144 | / | 0.991(T-test) | |
| Number of seizure years, median (range) | 5.5(1-21) | 11.0(3-35) | / | 0.068 (Mann-Whitney) | |
| Type of seizure | FAS | 5 | / | / | / |
| FIAS | 10 | / | / | / | |
| FAS + FIAS | 3 | / | / | / | |
| FAS + FBTCS | / | 2 | / | / | |
| FIAS+FBTCS | / | 19 | / | / | |
| Alertness | Alertness effect (M ± SD) | 0.106 ± 0.037 | 0.078 ± 0.034 | 0.090 ± 0.033 | 0.043(ANOVA) |
| No cue RT (M ± SD) ms | 669.49 ± 87.15 | 715.87 ± 129.06 | 606.29 ± 72.22 | 0.003(Kruskal-Wallis) | |
| Double cue RT median (range)ms | 616.32 (455.52-746.40) | 701.68 (569.89-1085.79) | 547.76 (457.38-708.38) | 0.003(Kruskal-Wallis) | |
| ASM (mono or polytherapy) | 5/13 | 7/14 | / | 0.708(Chi-square) | |
HCs Health controls, M Man, F Female, M ± SD Mean ± standard deviation, ASM Anti-seizure medications, FAS Focal aware seizures, FIAS Focal impaired awareness seizures, FBTCS Focal to bilateral tonic–clonic seizures, ANOVA One-way analysis of variance, χ2 Chi-square tests; NA
The demographic, clinical characteristic and alertness of the two subgroups with right TLE and HCs-1
| RTLE-non-FBTCS (11) | RTLE- FBTCS | HCs-1 | P value | ||
|---|---|---|---|---|---|
| Gender (M/F) | 5/6 | 6/5 | 5/6 | 0.886(Chi-square) | |
| Age (M ± SD) | 29.091 ± 8.240 | 34.818 ± 8.208 | 28.909 ± 6.379 | 0.138(ANOVA) | |
| Education years,median (range) | 15(9-16) | 15(9-16) | 16(12-17) | 0.059(Kruskal-Wallis) | |
| Hippocampal sclerosis (Yes or No) | 7/4 | 6/5 | / | 1.00 | |
| Age of epilepsy onset (M ± SD) | 20.909 ± 9.721 | 22.818 ± 9.527 | / | 0.647(T-test) | |
| Number of seizure years,median (range) | 5(1-21) | 13(6-20) | / | 0.080 (Mann-Whitney) | |
| Type of seizure | FAS | 2 | / | / | / |
| FIAS | 6 | / | / | / | |
| FAS + FIAS | 3 | / | / | / | |
| FAS + FBTCS | / | 1 | / | / | |
| FIAS+FBTCS | / | 10 | / | / | |
| Alertness | Alertness effect (M ± SD) | 0.099 ± 0.034 | 0.070 ± 0.031 | 0.085 ± 0.034 | 0.126(ANOVA) |
| No cue RT (M ± SD) | 688.49 ± 85.32 | 725.23 ± 165.39 | 670.69 ± 125.88 | 0.047(ANOVA) | |
| Double cue RT median (range) | 655.17 (455.52-746.40) | 632.94 (529.01-1082.13) | 518.72 (486.47-708.38) | 0.041(Kruskal-Wallis) | |
| AEDs (mono or polytherapy) | 3/8 | 2/9 | / | 0.611(Chi-square) | |
HCs Health controls, M Man, F Female, M ± SD Mean ± standard deviation, ASM Anti-seizure medications, FAS Focal aware seizures, FIAS Focal impaired awareness seizures, FBTCS Focal to bilateral tonic–clonic seizures, ANOVA One-way analysis of variance, χ2 Chi-square tests; NA
The demographic, clinical characteristic and alertness of the two subgroups with left TLE and HCs-2
| LTLE-non-FBTCS (7) | LTLE-FBTCS (10) | HCs-2 | P value | ||
|---|---|---|---|---|---|
| Gender (M/F) | 3/4 | 5/5 | 4/7 | 0.663(Chi-square) | |
| Age (M ± SD) | 30.714 ± 10.355 | 32.100 ± 8.761 | 27.091 ± 5.991 | 0.372(ANOVA) | |
| Education years,median (range) | 15(9-16) | 14(9-16) | 13(10-18) | 0.507(Kruskal-Wallis) | |
| Hippocampal sclerosis (Yes or No) | 1/6 | 6/4 | / | 0.166 | |
| Age of epilepsy onset (M ± SD) | 21.714 ± 13.499 | 21.600 ± 8.487 | / | 0.983(T-test) | |
| Number of seizure years, median (range) | 9(3-22) | 6.000(2.0-22) | / | 0.922(Mann-Whitney) | |
| Type of seizure | FAS | 3 | / | / | / |
| FIAS | 4 | / | / | / | |
| FAS + FIAS | / | / | / | / | |
| FAS + FBTCS | / | 1 | / | / | |
| FIAS+FBTCS | / | 9 | / | / | |
| Alertness | Alertness effect (M ± SD) | 0.117 ± 0.042 | 0.086 ± 0.038 | 0.086 ± 0.033 | 0.182(ANOVA) |
| No cue RT (M ± SD) | 624.87 ± 75.01 | 705.56 ± 79.96 | 604.02 ± 59.12 | 0.009(ANOVA) | |
| Double cue RT (M ± SD) | 572.95 ± 74.81 | 651.04 ± 81.62 | 554.58 ± 59.84 | 0.014(ANOVA) | |
| ASM (mono or polytherapy) | 3/4 | 5/5 | / | 0.772(Chi-square) | |
HCs Health controls, M Man, F Female, M ± SD Mean ± standard deviation, ASM Anti-seizure medications, FAS Focal aware seizures, FIAS Focal impaired awareness seizures, FBTCS Focal to bilateral tonic–clonic seizures, ANOVA One-way analysis of variance, χ2 Chi-square tests; NA
Fig. 1Comparisons of Neuropsychological results for the patients with TLE and HC. P-values represent significant ANOVA F-ratios. The significance of post hoc comparisons is denoted by *. A The results of alertness effect in two patient groups (TLE-non-FBTCS and TLE-FBTCS) and HC. B and C The results of the mean RT in no cue and double cue trials in two patient groups (TLE-non-FBTCS and TLE-FBTCS) and HC, respectively. D and E Same as B and C, but for the patients with right TLE and HC-1. F and G Same as B and C, but for the patients with left TLE and HC-1. ***P < 0.001, **0.001 < P < 0.01, * 0.01 < P < 0.05
Fig. 2The global characteristics of patients without FBTCS were significantly altered. P-values represent significant ANOVA F-tests. The significance of pairwise comparison t-test with Bonferroni-Holm correction for multiple comparisons are denoted by *. A, B, C, D and E show small-worldness, normalized clustering coefficient, normalized characteristic path length, global network efficiency and local network efficiency in two patient groups (TLE-non-FBTCS and TLE-FBTCS) and HC, respectively. F, G, H, I and J are the same as A, B, C, D and E but for the patients with right TLE and HC-1, respectively. And K, L, M, N and O are the same as (A), (B), (C), (D) and E but for the patients with Left TLE and HC-2, respectively. *** P < 0.001, ** 0.001 < P < 0.01, * 0.01 < P < 0.05
Fig. 3The nodal characteristic is diminished for the patients with right TLE-non-FBTCS. P-values represent significant ANOVA F-tests. A nodal efficiency in two patient groups (right TLE-non-FBTCS and right TLE-FBTCS) and HC-1. The significant alteration did not survive analysis by Bonferroni correction for pairwise comparison. B Location of the basal ganglia
Fig. 4Correlations of significantly altered topological properties and alertness in patients without FBTCS. A The correlation of global network efficiency and mean RT in double cue trials of patients without FBTCS. B The correlation of global network efficiency and mean RT in double cue trials of patients without FBTCS. C The correlation of characteristic path length and mean RT in no cue trials of patients without FBTCS. The threshold of corrected p-value was less than 0.0031 and r represented the correlation coefficient